| Source: |
| Type: protein kinase |
| MEK (Mitogen-Activated Protein Kinase Kinase) is a protein kinase that plays a crucial role in the regulation of cell growth, differentiation, and survival. MEK is often overexpressed or mutated, leading to the activation of downstream signaling pathways that promote cell growth, survival, and metastasis. MEK inhibitors have been developed as a therapeutic strategy to target cancer cells and inhibit their growth. |
| 1539- | Api, | LT, | Dietary flavones counteract phorbol 12-myristate 13-acetate-induced SREBP-2 processing in hepatic cells |
| - | in-vitro, | Liver, | HepG2 |
| 2606- | Ba, | Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma |
| - | Review, | HCC, | NA |
| 726- | Bor, | Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open |
| - | Review, | NA, | NA |
| 2908- | LT, | Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity |
| - | in-vitro, | Arthritis, | NA |
| 79- | QC, | Chemopreventive Effect of Quercetin in MNU and Testosterone Induced Prostate Cancer of Sprague-Dawley Rats |
| - | in-vivo, | Pca, | NA |
| 1499- | SFN, | Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway |
| - | in-vitro, | BC, | NA |
| 1276- | SIL, | Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells |
| - | in-vitro, | BC, | NA | - | in-vitro, | Thyroid, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:860 State#:1 Dir#:1
wNotes=0 sortOrder:rid,rpid